Tags

Type your tag names separated by a space and hit enter

MIRVASO (brimonidine tartrate) topical gel 0.33%.
Skinmed. 2014 Jan-Feb; 12(1):41-3.S

Authors

Abramovits W
No affiliation info available
Prato A
No affiliation info available
Vincent KD
No affiliation info available
Scheinfeld N
No affiliation info available
Gupta AK
No affiliation info available

MeSH

Administration, CutaneousAdrenergic alpha-2 Receptor AgonistsBrimonidine TartrateClinical Trials as TopicDermatologic AgentsGelsHumansQuinoxalinesRosacea

Pub Type(s)

Journal Article

Language

eng

PubMed ID

24720083

Citation

Abramovits, William, et al. "MIRVASO (brimonidine Tartrate) Topical Gel 0.33%." Skinmed, vol. 12, no. 1, 2014, pp. 41-3.
Abramovits W, Prato A, Vincent KD, et al. MIRVASO (brimonidine tartrate) topical gel 0.33%. Skinmed. 2014;12(1):41-3.
Abramovits, W., Prato, A., Vincent, K. D., Scheinfeld, N., & Gupta, A. K. (2014). MIRVASO (brimonidine tartrate) topical gel 0.33%. Skinmed, 12(1), 41-3.
Abramovits W, et al. MIRVASO (brimonidine Tartrate) Topical Gel 0.33%. Skinmed. 2014 Jan-Feb;12(1):41-3. PubMed PMID: 24720083.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - MIRVASO (brimonidine tartrate) topical gel 0.33%. AU - Abramovits,William, AU - Prato,Ana, AU - Vincent,Kimberly D, AU - Scheinfeld,Noah, AU - Gupta,Aditya K, PY - 2014/4/12/entrez PY - 2014/4/12/pubmed PY - 2014/5/7/medline SP - 41 EP - 3 JF - Skinmed JO - Skinmed VL - 12 IS - 1 SN - 1540-9740 UR - https://www.unboundmedicine.com/medline/citation/24720083/MIRVASO__brimonidine_tartrate__topical_gel_0_33_ DB - PRIME DP - Unbound Medicine ER -